Author

W.-X. Qin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

B. Evers· 1 shared C. Wang· 1 shared D. Gao· 1 shared G. Jin· 1 shared H. Jin· 1 shared L. Wang· 1 shared R. Beijersbergen· 1 shared R. R. Bernards· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B. Evers

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

phospho-ERK is a response biomarker to a combination of sorafenib and MEK inhibition in liver cancer

R. R. Bernards, C. Wang, H. Jin, D. Gao, B. Evers, G. Jin, Z. Xue, L. Wang, R. Beijersbergen, W.-X. Qin

This study identifies phospho-ERK as a biomarker for response to sorafenib and MEK inhibition in liver cancer, showing synergistic effects in tumors with high phospho-ERK levels.

bioRxiv · Jan 23, 2018Cancer Biology